-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How I Treat: Acute Lymphoblastic Leukemia Incorporating New Treatment Options (ticketed session for in-person participants)

Program: How I Treat
Saturday, December 7, 2024: 8:00 AM-9:00 AM
Aqua 314 (Hilton San Diego Bayfront)
Speaker:
Marlise R. Luskin, MD, Dana-Farber Cancer Institute
Disclosures:
Luskin: KITE: Honoraria; Jazz: Honoraria; AbbVie: Research Funding; Pfizer: Honoraria; Novartis: Honoraria, Research Funding.
See more of: How I Treat
<< Previous Session | Next Session >>